HealthCap logo

HealthCap

Europe, Stockholms Lan, Sweden, Stockholm

Description

HealthCap is a Stockholm-based venture capital firm focused on investments in multi-stage life sciences companies.

Investor Profile

HealthCap has made 123 investments, with 7 in the past 12 months and 24% as lead.

Stage Focus

  • Series A (32%)
  • Series B (28%)
  • Series Unknown (20%)
  • Series C (11%)
  • Series E (3%)
  • Post Ipo Equity (2%)
  • Seed (2%)
  • Series D (2%)
  • Private Equity (1%)

Country Focus

  • United States (42%)
  • Sweden (21%)
  • France (7%)
  • Germany (7%)
  • Ireland (5%)
  • Denmark (5%)
  • Switzerland (3%)
  • Canada (2%)
  • Finland (2%)
  • United Kingdom (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Medical Device
  • Biopharma
  • Life Science
  • Health Diagnostics
  • Personal Health
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does HealthCap frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 8
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 6
Ysios Capital
Europe, Pais Vasco, Spain, San Sebastian
Co-Investments: 8
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 8
Apax Partners
Europe, England, United Kingdom, London
Co-Investments: 8
Industrifonden
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 8
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 17
TPG Biotech
North America, California, United States, San Francisco
Co-Investments: 9
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 8
Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 9

Which angels does HealthCap often collaborate with?

Shared Deals: 1
John Bloom
North America, Indiana, United States, Indianapolis
Shared Deals: 1
LL
Europe, Stockholms Lan, Sweden, Stockholm
Shared Deals: 1

What are some of recent deals done by HealthCap?

Tribune Therapeutics

Stockholm, Stockholms Lan, Sweden

Tribune Therapeutics specializes in building promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.

BiotechnologyPharmaceuticalTherapeutics
Series AMar 26, 2025
Amount Raised: $24,838,523
HelloBetter

Berlin, Berlin, Germany

Leading provider of digital therapeutics for mental health: 10 DTx, 6 PDTx with universal reimbursement for 73m+ people, 33 clinical studies

Health CareMedical DeviceMental HealthmHealthPersonal HealthPsychologyTherapeutics
Series UnknownMar 5, 2025
Amount Raised: $6,371,950
ADCendo

Copenhagen, Hovedstaden, Denmark

ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs.

BiotechnologyHealth Care
Series BNov 25, 2024
Amount Raised: $135,000,000
SynOx Therapeutics

Dublin, Dublin, Ireland

SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors.

BiotechnologyMedicalTherapeutics
Series BOct 30, 2024
Amount Raised: $92,000,000
Kivu Bioscience

San Francisco, California, United States

Kivu Bioscience is a biotechnology company that focuses on developing next-generation antibody-drug conjugates to target cancer.

BiotechnologyHealth CareOncology
Series AOct 28, 2024
Amount Raised: $92,000,000
ADCendo

Copenhagen, Hovedstaden, Denmark

ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs.

BiotechnologyHealth Care
Series AMay 29, 2024
Amount Raised: $17,281,921
SynOx Therapeutics

Dublin, Dublin, Ireland

SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors.

BiotechnologyMedicalTherapeutics
Series BApr 22, 2024
Amount Raised: $75,000,000
Aro Biotherapeutics

Philadelphia, Pennsylvania, United States

Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Series BNov 28, 2023
Amount Raised: $41,500,000
Rampart Bioscience

La Jolla, California, United States

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

BiopharmaBiotechnologyMedicalTherapeutics
Series AOct 24, 2023
Amount Raised: $85,000,000
Vicore Pharma

Mölndal, Vastra Gotaland, Sweden

Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders.

BiopharmaBiotechnologyPharmaceutical
Post Ipo EquityJun 9, 2023
Amount Raised: $46,180,204